GW Pharmaceuticals plc announced that the company has appointed Julian Gangolli to the Board of Directors with immediate effect. This follows the announcement on 19 May 2015 of Mr. Gangolli's appointment to the newly created position of President, North America. Mr. Gangolli, was, from 2004 until April 2015, President of the North American Pharmaceutical division of Allergan Inc. As a Corporate Vice President and member of the Executive Committee, Allergan's most senior leadership team overseeing worldwide operations.

Prior to Allergan, Mr. Gangolli was Vice President, Sales and Marketing at VIVUS Inc. where he established from inception a fully functioning commercial operation. Prior to VIVUS, Mr. Gangolli held roles at Syntex Pharmaceuticals Inc. and Ortho-Cilag Pharmaceuticals Ltd. in the UK. He grew up and was educated in the UK and is a U.S. citizen.